Days Before Christmas, Theranos Secures $100 Million in New Funding
Posted by EditorDavid on 24th December 2017
| 331 views

link to original article

An anonymous reader quotes Fortune:
Call it a Christmas miracle — albeit of a rather perverse sort. Theranos, the digraced medical-technology startup that infamously inflated the capabilities of its devices, has secured $100 million in new funding in the form of a loan. The loan, reported by the Wall Street Journal, will come from Fortress Investment Group. Fortress, whose other underdog bets include a private passenger rail line under construction in Florida, is set to be acquired by Japan’s SoftBank. Theranos was reportedly on the verge of bankrutpcy…

By the end of 2016, the company reportedly still had $200 million in cash on hand, but had sharply limited prospects for attracting more capital. It has since settled a major lawsuit with Walgreens, a former client, for an undisclosed but likely substantial sum. According to the Journal, the Fortress loan is expected to keep Theranos solvent through 2018. That will give the company more time for its ongoing effort to reboot as a medical device manufacturer, rather than a testing service.
The loan is conditional on “achieving certain product and operational milestones,” notes Fortune, adding “It’s unclear whether those might include positive outcomes for the multiple investigations and lawsuits still facing the company.”

Read more of this story at Slashdot.

Please disable your AdBlocker so our free service can continue delivering you breaking news, insightful analysis, and a collection of aggregated content that will keep you informed like no other.